1. Alvotech faces a legal investigation regarding potential securities law violations. 2. The FDA issued a Complete Response Letter for Alvotech's AVT05 application. 3. Alvotech's stock experienced a 34.25% decline following FDA news. 4. The investigation also includes Beyond Meat for unspecified business practices.
FAQ
Why Bearish?
The FDA's Complete Response Letter is a serious setback, impacting investor sentiment negatively.
How important is it?
The legal investigation and FDA setback could significantly deter investor interest in ALVO.
Why Short Term?
Immediate investor reactions to FDA news may lead to further selling pressure on ALVO.
Related Companies
NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Beyond Meat, Inc. (NASDAQ:BYND) and Alvotech (NASDAQ:ALVO). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
Beyond Meat, Inc. (NASDAQ:BYND)
- On October 24, 2025, Beyond Meat announced that it "expects to record a non-cash impairment charge for the three months ended September 27, 2025, related to certain of its long-lived assets," which it "expected to be material." On this news, the price of Beyond Meat stock dropped roughly 23%, from $2.84 per share on October 23, 2025 to $2.185 per share on October 24, 2025.
- Then, on November 3, 2025, the company delayed its earnings announcement for 3Q 25 as it needed more time to complete the impairment review. This news caused Beyond Meat stock to decline substantially during the trading day on November 3, 2025.
- For more information on the Beyond Meat investigation go to: https://bespc.com/cases/BYND
Alvotech (NASDAQ:ALVO)
- On November 3, 2025, Alvotech received a Complete Response Letter from the FDA regarding its AVT05 BLA biologics license application following a failed facility inspection in July 2025. On this news, Alvotech's stock fell $2.62, or 34.25%, to close at $5.03 per share.
- For more information on the Alvotech investigation go to: https://bespc.com/cases/ALVO
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X.
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com
